P61964 (WDR5_HUMAN) Homo sapiens (Human)

WD repeat-containing protein 5 UniProtKBInterProSTRINGInteractive Modelling

334 aa; Sequence (Fasta) 43 identical sequences

Sequence Features

 107Important for interaction with histone H3
 133Important for interaction with histone H3
 263Important for interaction with histone H3
 322Important for interaction with histone H3
 208T -> M (de novo variant found in a patient with childhood apraxia of speech; unknown pathological significance)VAR_081531
 39-72WD40 repeat
IPR001680PF00400
 79-115WD40 repeat
IPR001680PF00400
 119-157WD40 repeat
IPR001680PF00400
 161-199WD40 repeat
IPR001680PF00400
 203-242WD40 repeat
IPR001680PF00400
 246-287WD40 repeat
IPR001680PF00400
 293-331WD40 repeat
IPR001680PF00400

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Modulating Protein-Protein Interactions with Visible Light Peptide Backbone Switches Heteromer
G2XKQ0;
NA;K;6iam29-334
WDR5 and Histone H3 Lysine 4 dimethyl complex at 2.1 angstrom Heteromer
P68431;
2cnx29-334
WDR5 in complex with influenza NS1 C-terminal tail Heteromer
P03495;
17×UNX;4o4530-334
X-ray structure of WDR5-MLL3 Win motif peptide binary complex Heteromer
Q8NEZ4;
4ery31-334
Crystal structure of WDR5 in complex with the WDR5-interacting motif of MLL2 Heteromer
O14686;
SO4;BTB;3uvk31-334
Crystal structure of the KANSL1-WDR5 complex. Heteromer
Q7Z3B3;
GOL;4cy131-334
X-ray structure of WDR5-SETd1a Win motif peptide binary complex Heteromer
O15047;
4ewr31-334
Crystal structure of WDR5 in complex with the WDR5-interacting motif of MLL4 Heteromer
Q9UMN6;
3uvm31-334
X-ray structure of WDR5-MLL1 Win motif peptide binary complex Heteromer
Q03164;
4esg31-334
Structure of WDR5 bound to MLL1 peptide Heteromer
Q03164;
SO4;3eg631-334
X-ray structure of WDR5-MLL4 Win motif peptide binary complex Heteromer
Q9UMN6;
4erz31-334
Crystal structure of WDR5 in complex with the WDR5-interacting motif of SET1A Heteromer
O15047;
3uvn31-334
X-ray structure of WDR5-SETd1b Win motif peptide binary complex Heteromer
Q9UPS6;
4es031-334
Crystal structure of WDR5 in complex with MYC MbIIIb peptide Heteromer
P01106;
TRS;EDO;4y7r31-334
WDR5 in complex with unmodified H3K4 peptide Heteromer
Q6P823;
2h9m31-334
X-ray structure of WDR5-MLL2 Win motif peptide binary complex Heteromer
O14686;
4erq31-334
WDR5 in complex with trimethylated H3K4 peptide Heteromer
Q6P823;
2h9p31-334
Crystal structure of the KANSL1-WDR5-KANSL2 complex. Heteromer
Q7Z3B3; Q9H9L4;
4cy231-334
WDR5 in complex with monomethylated H3K4 peptide Heteromer
Q6P823;
2h9n31-334
Crystal structure of WDR5 in complex with the WDR5-interacting motif of SET1B Heteromer
Q9UPS6;
3uvo31-334
Crystal structure of WDR5 in complex with the WDR5-interacting motif of MLL3 Heteromer
Q8NEZ4;
3uvl31-334
WDR5 and unmodified Histone H3 complex at 2.25 angstrom Heteromer
P68431;
2co031-334
Structural and biochemical insights into MLL1 core complex assembly and regulation. Heteromer
Q03164; Q15291;
3p4f31-334
WDR5 IN COMPLEX WITH AN RBBP5 PEPTIDE RECRUITED TO NOVEL SITE Heteromer
P61965; Q8BX09;
GOL;2xl231-334
Crystal structure of WDR5-Mb(S4) monobody complex Heteromer
6byn31-334
'Symmetric Dimethylation of H3 Arginine 2 is a Novel Histone Mark that Supports Euchromatin Maint... Heteromer
P68431;
4a7j32-334
WDR5 IN COMPLEX WITH AN RBBP5 PEPTIDE AND HISTONE H3 PEPTIDE Heteromer
P61965; P68433; Q8BX09;
GOL;2xl332-334
Cryo-EM structure of MLL1 in complex with RbBP5 and WDR5 bound to the nucleosome Heteromer
P02281; P06897; P62799; P84233; Q03164; Q15291; Q9C005; Q9UBL3;
ZN;SAH;6pwv32-334
Cryo-EM structure of MLL1 in complex with RbBP5 and WDR5 bound to the nucleosome Heteromer
P02281; P06897; P62799; P84233; Q03164; Q15291;
ZN;SAH;6pww32-334
Structural basis of WDR5-MLL interaction Heteromer
Q03164;
SO4;3emh33-332
Cryo-EM structure of human MLL1-ubNCP complex (3.2 angstrom) Heteromer
P02281; P06897; P62799; P62979; P84233; Q03164; Q15291; Q9UBL3;
ZN;SAH;GLN;LYS;6kiu33-332
Cryo-EM structure of human MLL1-ubNCP complex (4.0 angstrom) Heteromer
P02281; P06897; P62799; P62979; P84233; Q03164; Q15291; Q9UBL3;
ZN;SAH;6kiv33-332
Cryo-EM structure of human MLL3-ubNCP complex (4.0 angstrom) Heteromer
P02281; P06897; P62799; P62979; P84233; Q15291; Q8NEZ4; Q9UBL3;
ZN;6kiw33-332
Cryo-EM structure of human MLL1-NCP complex, binding mode1 Heteromer
P02281; P06897; P62799; P84233; Q03164; Q15291; Q9UBL3;
ZN;SAH;GLN;LYS;6kix33-332
Cryo-EM structure of human MLL1-NCP complex, binding mode2 Heteromer
P02281; P06897; P62799; P84233; Q03164; Q15291; Q9UBL3;
ZN;SAH;6kiz33-332
Structure of wdr5monomer CL;2gnq11-334
'Discovery and Structure-Based optimization of potent and selective WDR5 inhibitors containing a ...monomer Q41;6ucs23-334
'Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC pro...monomer Q0Y;6u6w24-334
'Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC pro...monomer Q1M;6u8b24-334
'Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC pro...monomer Q1J;6u8024-334
Crystal structure of human WDR5 in complex with compound 9emonomer 14×UNX;GOL;5MO;EDO;CL;5eap24-334
WDR5delta23monomer SO4;2h9l24-334
Crystal structure of human WD repeat domain 5 with compound MM-401monomer 4gm924-334
'Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affin...monomer HLP;6e1z28-334
Crystal structure of human WD repeat domain 5 with compound MM-402monomer 4gmb28-334
Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Us...monomer G2V;DMS;6dai30-334
Crystal structure of human WD REPEAT DOMAIN 5 in complex with 2-chloro-4-fluoro-3-methyl-N-[2-(4-...monomer 24×UNX;IA9;EDO;4ia930-334
Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Us...monomer G2D;6das30-334
Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Us...monomer NA;FZM;6d9x30-334
Histone H3 recognition and presentation by the WDR5 module of the MLL1 complexmonomer 2h6k30-334
WDR5 in complex with a WIN site inhibitormonomer DMS;SO4;HHM;6dya30-334
'Structural basis for the specific recognition of methylated histone H3 lysine 4 by the WD-40 pro...monomer 2g9a29-333
Crystal structure of human WDR5 in complex with compound OICR-9429monomer UNX;35Q;4ql131-334
Histone H3 recognition and presentation by the WDR5 module of the MLL1 complexmonomer 2h6n31-334
'Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC pro...monomer Q0M;6u5y31-334
'Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC pro...monomer Q1P;Q1S;6u8l31-334
'Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affin...monomer HLS;SO4;6e2231-334
Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Us...monomer DMS;G1Y;6dak31-334
'Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC pro...monomer Q1G;6u8o31-334
WDR5 bound to inhibitor MM-589monomer 9BA;SO4;EDO;5vfc31-334
WDR5delta23 bound to (2-(3-phenylpropyl)-1H-imidazol-4-yl)methanolmonomer OGY;CL;6pg831-334
WDR5delta23 bound to N-(4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)acetamidemonomer OH7;SO4;CL;6pg631-334
WDR5delta23 bound to N-(4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)benzamidemonomer OH1;6pg931-334
Histone H3 recognition and presentation by the WDR5 module of the MLL1 complexmonomer 2h6831-334
Crystal structure of human WDR5 in complex with compound 9dmonomer UNX;5MQ;EDO;5ear31-334
Crystal structure of human WD repeat domain 5 with compoundmonomer 17×UNX;SO4;0BW;EDO;CL;3ur431-334
Crystal structure of WDR5, WD repeat domain 5 in complex with compound SGC-DS-MT-0345monomer UNX;CL;EDO;37F;4qqe31-334
Crystal structure of human WDR5 in complex with compound 9hmonomer 13×UNX;5ML;CL;EDO;GOL;5eal31-334
Crystal structure of human WDR5 in complex with compound 9omonomer 11×UNX;5MN;EDO;5eam31-334
'Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC pro...monomer Q0S;6u5m31-334
Crystal structure of human WD repeat domain 5 with compoundmonomer UNX;NP7;EDO;3smr31-334
Histone H3 recognition and presentation by the WDR5 module of the MLL1 complexmonomer 2h6q31-334
WDR5 in complex with a WIN site inhibitormonomer DMS;HH7;SO4;6dy731-334
'Structural basis for the specific recognition of methylated histone H3 lysine 4 by the WD-40 pro...monomer 2g9930-333
WDR5 in Complex with Dimethylated H3K4 Peptidemonomer 2o9k31-334
WDR5 in complex with MLL Win motif peptidomimeticmonomer 5sxm31-334
WDR5delta23 bound to (2-butyl-1H-imidazol-4-yl)methanolmonomer OHJ;6pg331-334
Crystal structure of WDR5 mutant (S62A)monomer 3mxx31-334
Crystal structure of WDR5 mutant (W330F)monomer 3n0d31-334
Crystal structure of WDR5 mutant (W330Y)monomer 3n0e31-334
Crystal structure of human WD repeat domain 5 with compound MM-102monomer 4gm831-334
Crystal structure of human WD repeat domain 5 with compound MM-101monomer 4gm331-334
Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Us...monomer HLM;6e1y32-334
Crystal of WDR5 (apo-form)monomer 2h1432-334
WDR5delta32 bound to peptidomimeticmonomer OK4;SO4;6pgd32-334
WDR5delta32 bound to N-(4-(4-(hydroxymethyl)-1H-imidazol-2-yl)butyl)acrylamidemonomer SO4;OJP;6pgf32-334
Crystal structure of WDR5/histone H3 complexmonomer 2h1332-334
WDR5delta32 bound to (2-methyl-1H-imidazol-4-yl)methanolmonomer OHG;SO4;6pg432-334
'Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affin...monomer HLJ;6e2332-334
'Fine-tuning the stimulation of MLL1 methyltransferase activity by a histone H3 based peptide mim...monomer 3psl32-334
WDR5delta32 bound to N-(4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)-2-phenylacetamidemonomer OJG;SO4;6pgb32-334
WDR5delta32 bound to ethyl 3-(4-(hydroxymethyl)-1H-imidazol-2-yl)propanoatemonomer OJM;SO4;EDO;6pge32-334
WDR5delta32 bound to methyl benzyl(4-(4-(hydroxymethyl)-1H-imidazol-2-yl)butyl)carbamatemonomer OJJ;SO4;6pgc32-334
WDR5delta32 bound to benzyl (4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)carbamatemonomer OHV;SO4;6pg532-334
WD repeat-containing protein 5 complexed with N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-...monomer Q6S;6ufx32-334
WDR5delta32 bound to (2-(3-methoxy-3-phenylpropyl)-1H-imidazol-4-yl)methanolmonomer OH4;PEG;6pg732-334
WDR5delta32 bound to methyl (4-(4-(hydroxymethyl)-1H-imidazol-2-yl)butyl)carbamatemonomer OGM;SO4;6pga32-334
Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Us...monomer DMS;G2J;SO4;6dar31-332
Modulation of MLL1 Methyltransferase Activitymonomer 7DC;5m2333-332
Modulation of MLL1 Methyltransferase Activitymonomer 7DU;5m2533-332